High Content Screening Market - Growth, Trends, and Forecast (2019 - 2024)

The market is segmented by Type of Product (Instruments, Consumables, Software, Services, and Accessories), Application, End User, and Geography.

Market Snapshot

HCS1
Study Period:

2016-2024

Base Year:

2018

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

Key Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

The high content screening market was valued at around USD 600 million and is expected to reach a market value of approximately USD 1.05 billion, by registering a growth rate of 9.8%.

Under the conventional method of toxicity studies, large libraries are screened in search of potential drug candidates. This method is expensive, resource- and time-consuming, and has a low success rate. Consequently, high content screening (HCS) solutions for testing the potential toxicity of chemicals and complex substances are being adopted by pharmaceutical companies to improve in-vitro toxicity testing by reducing the time and cost. The need for cost containment in pharmaceutical R&D, advancements in informatics solutions and imaging instruments, and government funding and venture capital investments across developed markets are the major factors driving the growth of the high-content screening (HCS) market.  The increasing number of contract research organizations providing HCS outsourcing services and application of HCS in personalized medicine, present significant growth opportunities in the market.

 

Scope of the Report

High-content screening (HCS) is a method that is used in biological research and drug discovery to identify substances, such as small molecules, peptides, or RNAi that alter the phenotype of a cell in a desired manner. High-content screening includes any method used to analyze whole cells or components of cells with a simultaneous readout of several parameters.

Product
Instruments
Cell Imaging and Analysis Systems
Flow Cytometers
Consumables
Reagents and Assay Kits
Microplates
Other Consumables
Software
Services
Accessories
Application
Primary and Secondary Screening
Target Identification and Validation
Toxicity Studies
Compound Profiling
Other Applications
End User
Pharmaceutical and Biotechnology Companies
Academic and Government Institutions
Contract Research Organisation
Geography
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

On the basis of Product Type, Instrument segment led the global market in 2018

Based on the product segment, the high content screening market is further segmented into instruments, consumables, software, services, and accessories. The market for HCS software is expected to increase with the highest CAGR between 2019 and 2024. Among all high content screening products, the instrument segment occupies the largest share of the market. The large share of this segment is attributed to advances in instrumentation and automation techniques and high prices of HCS instruments.

HCS2

To understand key trends, Download Sample Report

APAC region is expected to exhibit the highest growth rate

The high content screening market in APAC is expected to increase at the highest CAGR during the forecast period. Factors, such as increasing drug discovery research, government initiatives, growing focus of multinational companies on emerging markets, and developing R&D infrastructure are driving the growth of the HCS market in this region.

HCS3

To understand geography trends, Download Sample Report

Competitive Landscape

For compound profiling applications, many pharmaceutical companies are partnering with contract research organizations to identify potential candidates for drug discovery. The HCS market is highly competitive in nature. The majority of large global players are based out of the United States and these players have expertise in other biotechnology/medical-technology verticals as well, which helps them in controlling the major market share, through a presence in the allied markets.

Major Players

  1. GE Healthcare
  2. Thermo Fisher Scientific Inc.
  3. Danaher Corporation
  4. PerkinElmer Inc.
  5. Becton, Dickinson and Company

* Complete list of players covered available in the table of contents below

HCS4

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Need for Cost Containment in Pharmaceutical R&D

      2. 4.2.2 Government Funding and Venture Capital Investments Across Developed Markets

      3. 4.2.3 Advancements in Informatics Solutions and Imaging Instruments

    3. 4.3 Market Restraints

      1. 4.3.1 Lower Adoption of HCS Instruments Due to Their High Prices

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Product

      1. 5.1.1 Instruments

        1. 5.1.1.1 Cell Imaging and Analysis Systems

        2. 5.1.1.2 Flow Cytometers

      2. 5.1.2 Consumables

        1. 5.1.2.1 Reagents and Assay Kits

        2. 5.1.2.2 Microplates

        3. 5.1.2.3 Other Consumables

      3. 5.1.3 Software

      4. 5.1.4 Services

      5. 5.1.5 Accessories

    2. 5.2 Application

      1. 5.2.1 Primary and Secondary Screening

      2. 5.2.2 Target Identification and Validation

      3. 5.2.3 Toxicity Studies

      4. 5.2.4 Compound Profiling

      5. 5.2.5 Other Applications

    3. 5.3 End User

      1. 5.3.1 Pharmaceutical and Biotechnology Companies

      2. 5.3.2 Academic and Government Institutions

      3. 5.3.3 Contract Research Organisation

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 US

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 UK

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East & Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East & Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 GE Healthcare

      2. 6.1.2 Danaher Corporation

      3. 6.1.3 Perkinelmer Inc.

      4. 6.1.4 Thermo Fisher Scientific Inc.

      5. 6.1.5 Becton, Dickinson and Company

      6. 6.1.6 Biotek Instruments Inc.

      7. 6.1.7 Bio-Rad Laboratories Inc.

      8. 6.1.8 Yokogawa Electric Corporation

      9. 6.1.9 Merck Millipore

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please Enter a Valid Message!


Complete your payment details below

Shipping & Billing Information

Payment Information